Incidence of liver disease in people with HFE mutations

Gut

Volumn 46, Issue 3, 2000, Pages 401-404

  Willis, G ^a   Wimperis, J Z ^a   Lonsdale, R ^a   Fellows, I W ^a   Watson, M A ^a   Skipper, L M ^a   Jennings, B A ^a  

^a NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

Author keywords

C282Y; H63D; Haemochromatosis, HLA H; Penetrance

Indexed keywords

DNA;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; GENE AMPLIFICATION; GENE MUTATION; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FIBROSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PENETRANCE; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 0034105259     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.3.401     Document Type: Article

References (26)

1. Edwards CQ, Griffen LM, Goldgar D, et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1998;318:1355-62.
2. Merryweather-Clarke AT, Pointon JJ, Shearman JD, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
3. Willis G, Jennings BA, Goodman E, et al. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cells Mol Dis 1997;23:288-91.
4. Milder MS, Cook JD, Stray S, et al. Idiopathic hemochromatosis, an interim report. Medicine 1980;59:34-49.
5. Niederau C, Fischer R, Purschel A, et al. Long term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
6. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-72.
7. Fargion S, Mandelli C, Piperno A, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992;15:655-9.
8. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
9. Cotler SJ, Bronner MP, Press RD, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998;29:257-62.
10. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria. Gastroenterology 1998:114:319-23.
11. Bassett ML, Leggett BA, Halliday JW, et al. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. Hepatology 1997;27:517-24.
12. Burt MJ, George PM, Upton JD, et al. The significance of haemochromatosis gene mutations in the general population: Implications for screening. Gut 1998;43:830-6.
13. Merryweather-Clarke AT, Worwood M, Parkinson L, et al. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br J Haematol 1998;101:369-73.
14. Willis G, Wimperis JZ, Lonsdale R, et al. Haemochromatosis gene mutation in hepatocellular cancer. Lancet 1997; 350:565-6.
15. Davies TW. A Report on Cancer Incidence in 1994. Cambridge, UK: East Anglian Cancer Registry, 1995.
16. The UK Haemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997;41:841-4.
17. Barker M. Health and Personal Social Services Statistics for England. London, UK: HMSO, 1995.
18. Bomford A, Williams R. Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med 1976;45:611-23.
19. Burke W, Thompson E, Khoury MJ, et al. Hereditary hemochromatosis: Gene discovery and its implications for population screening. JAMA 1998;280:172-8.
20. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996;22:187-94.
21. Symmons PM, Barrett EM, Bankhead CR, et al. The incidence of rheumatoid arthritis in the United Kingdom: Results from the Norfolk arthritis register. Br J Rheumatol 1994;33:735-9.
22. Frayling T, Elard S, Grove J, et al. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet 1998;351:1933-4.
23. Yang Q, McDonnell SM, Khoury MJ, et al. Hemochromatosis-associated mortality in the United States from 1979 to 1992: An analysis of multiple case mortality data. Ann Intern Med 1998;129:946-53.
24. Willis G, Wimperis JZ, Smith KC, et al. HFE (haemochromatosis gene) C282Y homozygotes in an elderly male population. Lancet 1999;354:221-2.
25. Bhavnani M, Bhattacharyya A, Lloyd D, et al. Prevalence of genetic haemochromatosis (GH) in patients with raised serum alanine aminotransferase. Blood 1998;92:1329a.
26. Crawford DHG, Halliday JW, Summers KM, et al. Concordance of iron storage in siblings with genetic hemochromatosis: Evidence for a predominantly genetic effect on iron storage. Hepatology 1993;17:833-7.